GE HealthCare Technologies Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $2.08B | $1.99B | $1.57B | $1.92B | $2.25B |
| Depreciation & Amortization | — | — | — | — | — |
| Depreciation | $287.0M | $268.0M | $248.0M | $228.0M | $225.0M |
| Amortization | $291.0M | $312.0M | $362.0M | $405.0M | $400.0M |
| Stock-Based Compensation | $130.0M | $125.0M | $114.0M | $67.0M | $76.0M |
| Net Cash from Operating Activities | $1.99B | $1.96B | $2.10B | $2.13B | $1.61B |
| Investing Activities | |||||
| Capital Expenditures | $482.0M | $401.0M | $387.0M | $310.0M | $248.0M |
| Business Acquisitions | $378.0M | $313.0M | $147.0M | $0 | $1.48B |
| Net Cash from Investing Activities | $-1.05B | $-914.0M | $-558.0M | $-398.0M | $-1.76B |
| Financing Activities | |||||
| Dividends Paid | $64.0M | $55.0M | $41.0M | $0 | $0 |
| Stock Repurchases | $200.0M | $0 | $0 | — | — |
| Net Cash from Financing Activities | $617.0M | $-573.0M | $-478.0M | $-822.0M | $-263.0M |
| Net Change in Cash | $1.62B | $387.0M | $1.06B | $890.0M | $-451.0M |
| Free Cash Flow | $1.51B | $1.55B | $1.71B | $1.82B | $1.36B |